Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Operating Expenses (2022 - 2026)

Genelux (GNLX) posted Operating Expenses of $9.2 million for Q1 2026, down 2.64% on a QoQ basis from $9.4 million in Q4 2025, and up 17.34% year-over-year from $7.8 million in Q1 2025.

Analysis

Genelux (GNLX) Operating Expenses (2022 - 2026) Analysis & Trends

Genelux has reported Operating Expenses for 5 years, with the latest figure at $9.2 million in Q1 2026.

  • On a quarterly basis, Operating Expenses rose 17.34% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $34.6 million, a 10.13% increase from a year earlier, with the FY2025 full-year figure at $33.2 million, up 4.79% from the prior year.
  • Operating Expenses was $9.2 million for Q1 2026 at Genelux, down from $9.4 million in the prior quarter.
  • The five-year high for Operating Expenses was $9.7 million in Q4 2024, with the low at $3.2 million in Q4 2022.
  • Average Operating Expenses over 5 years is $7.1 million, with a median of $7.0 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2025: Operating Expenses jumped 121.41% in 2023, then decreased 3.78% in 2025.
  • Over 5 years, Operating Expenses stood at $3.2 million in 2022, then soared by 121.41% to $7.0 million in 2023, then soared by 39.24% to $9.7 million in 2024, then declined by 3.36% to $9.4 million in 2025, then slipped by 2.64% to $9.2 million in 2026.
  • The last three Operating Expenses figures came in at $9.2 million (Q1 2026), $9.4 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 367.83 Mn
10 Genelux 108.17 Mn 108.17 Mn - 9.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 9.17 Mn
Dec 31, 2025 9.42 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.79 Mn
Mar 31, 2025 7.82 Mn
Dec 31, 2024 9.75 Mn
Sep 30, 2024 6.94 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 8.12 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 5.31 Mn
Jun 30, 2023 5.40 Mn
Mar 31, 2023 6.63 Mn
Dec 31, 2022 3.16 Mn
Sep 30, 2022 4.66 Mn